Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

- PMLiVE

UCB and MRC join forces on novel antibody discovery platform

Will provide UK scientists with access to up-to-date technologies

- PMLiVE

PRC Clinical makes key management appointments

And launches operation in the East Coast of the US

- PMLiVE

Ogilvy CommonHealth releases pharmacy report

The Power of Pharmacy debates its role and the change it faces

- PMLiVE

The art and science of local KOLs

Marketers can stay ahead of the curve with regional knowledge

NHS to expand video and email consultation pilots

Move is part of plans to increase patient access to GPs and pharmacists

- PMLiVE

Start me up: The virtue of patience

Regardless of an agency's size, the hardest lesson to learn is that of being patient

- PMLiVE

Nurturing innovation in a tough environment

Much has been achieved in the UK in recent years, but the NHS still has a way to go

- PMLiVE

Prioritise educating GPs over patients, says patient advocate

Jack Whelan says that patients are ‘no different to the man on the street’ with health knowledge 

Webinar: How to conduct effective market research in emerging markets

Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge.

Inizio

- PMLiVE

Merck Serono joins CAR-T race with $941m Intrexon deal

Will collaborate on therapy to recognise and attack antigens on tumour cells

Webinar: Uncovering hidden insights into patient compliance

Pharma companies are increasingly looking for ways to provide “beyond the pill" services to support patients with the management of their disease. Adherence tools and programs encourage patients to stay compliant with their treatment...

Inizio

Webinar: The patient journey: Time to look beyond the physician?

Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links